Epigenomics AG Stock Xetra
Equities
DE000A1K0516
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
Sales 2024 * | 150K 161K 219K | Sales 2025 * | - | Capitalization | 1.42M 1.52M 2.07M |
---|---|---|---|---|---|
Net income 2024 * | - 0 0 | Net income 2025 * | - 0 0 | EV / Sales 2024 * | -4.81 x |
Net cash position 2024 * | 2.14M 2.29M 3.13M | Net cash position 2025 * | 1.69M 1.81M 2.48M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.4
x | P/E ratio 2025 * |
-2.42
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.77% |
1st Jan change | Capi. | |
---|---|---|
-20.45% | 10.82B | |
+43.17% | 3.25B | |
-35.86% | 2.11B | |
-17.21% | 2.08B | |
-29.81% | 1.48B | |
+17.56% | 1.02B | |
-4.37% | 733M | |
-37.00% | 391M | |
-46.94% | 383M |